Friday, December 26, 2025
ADVT 
International

Probe launched into input received from US concerning national security: Jaishankar

Darpan News Desk IANS, 07 Dec, 2023 12:26 PM
  • Probe launched into input received from US concerning national security: Jaishankar

New Delhi, Dec 7 (IANS) External Affairs Minister S. Jaishankar on Thursday said that the government has launched an inquiry on the input it received from the US as it has a bearing on India's national security.

Jaishankar made the remarks while responding to a question by CPI-M Rajya Sabha MP John Brittas.

Brittas said that there have been numerous reports that an Indian official has been implicated by the US authorities on account of an alleged attempt to kill a US citizen.

He further said that it has been widely reported that the Indian government was applying its mind and going through the input of the US government on the basis of an inquiry.

He also said that on other counts, there have been reports about India rebutting the stand of the Canadian government.

"Is it a fact that we are not having equitable treatment? And what is the status of the charges and allegations raised by the US authorities?" Brittas questioned.

Responding to his question, Jaishankar said: "The matter is not directly connected to the visits of the Union Ministers but nevertheless, since this has been asked, I want to clarify to the Member that so far the US is concerned, certain inputs were given to us as part of our security cooperation with the US.

"Those inputs were of concern to us because they were related to the nexus of organised crime, trafficking and other matters. So, because it has a bearing on our own national security, it was decided to institute an inquiry into the matter and an inquiry committee has been constituted.

"So far as Canada is concerned, no specific evidence or input was provided to us. So, the question of equitable treatment of two countries, one of whom has provided input and one who has not, does not arise," the External Affairs Minister added.

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report